Paul M Kaye - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Paul M Kaye

Showing results (121-130 of 136) with videos related to

Pageof 14

Sort By:

Wellcome Open Research|October 25, 2021

A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study)Vivak Parkash, Helen Ashwin, Jovana Sadlova, et al.

Nature Medicine|August 2, 2024

Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasisVivak Parkash, Helen Ashwin, Shoumit Dey, et al.

The Journal of Clinical Investigation|March 1, 2024

Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasisNidhi S Dey, Sujai Senaratne, Vijani Somaratne, et al.

The Journal of Clinical Investigation|October 5, 2021

Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasisNidhi S Dey, Sujai Senaratne, Vijani Somaratne, et al.

Plos Neglected Tropical Diseases|August 29, 2024

Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous LeishmaniasisShalindra Ranasinghe, Sujai Senarathne, Vijani Somaratne, et al.

Nature Communications|January 12, 2021

Characterization of a new Leishmania major strain for use in a controlled human infection modelHelen Ashwin, Jovana Sadlova, Barbora Vojtkova, et al.

Ebiomedicine|December 24, 2023

Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19Luke Milross, Bethany Hunter, David McDonald, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2014

Tissue requirements for establishing long-term CD4+ T cell-mediated immunity following Leishmania donovani infectionPatrick T Bunn, Amanda C Stanley, Fabian de Labastida Rivera, et al.

Journal of Hepatology|June 6, 2016

Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functionsLynette Beattie, Amy Sawtell, Jason Mann, et al.

Plos Pathogens|October 15, 2011

Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infectionAmanda C Stanley, Fabian de Labastida Rivera, Ashraful Haque, et al.

Pageof 14

Search research articles

Showing results (121-130 of 136) with videos related to

Sort By:

Pageof 14

Wellcome Open Research|October 25, 2021

A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study)Vivak Parkash, Helen Ashwin, Jovana Sadlova, et al.

Nature Medicine|August 2, 2024

Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasisVivak Parkash, Helen Ashwin, Shoumit Dey, et al.

The Journal of Clinical Investigation|March 1, 2024

Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasisNidhi S Dey, Sujai Senaratne, Vijani Somaratne, et al.

The Journal of Clinical Investigation|October 5, 2021

Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasisNidhi S Dey, Sujai Senaratne, Vijani Somaratne, et al.

Plos Neglected Tropical Diseases|August 29, 2024

Development of a Core Outcome Measure Instrument; "LeishCOM_LCL", for Localised Cutaneous LeishmaniasisShalindra Ranasinghe, Sujai Senarathne, Vijani Somaratne, et al.

Nature Communications|January 12, 2021

Characterization of a new Leishmania major strain for use in a controlled human infection modelHelen Ashwin, Jovana Sadlova, Barbora Vojtkova, et al.

Ebiomedicine|December 24, 2023

Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19Luke Milross, Bethany Hunter, David McDonald, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2014

Tissue requirements for establishing long-term CD4+ T cell-mediated immunity following Leishmania donovani infectionPatrick T Bunn, Amanda C Stanley, Fabian de Labastida Rivera, et al.

Journal of Hepatology|June 6, 2016

Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functionsLynette Beattie, Amy Sawtell, Jason Mann, et al.

Plos Pathogens|October 15, 2011

Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infectionAmanda C Stanley, Fabian de Labastida Rivera, Ashraful Haque, et al.

Pageof 14